Literature DB >> 8490198

Intratunical injection of methotrexate for the treatment of seminoma of the testicle.

A Shafik1.   

Abstract

A bilateral testicular seminoma in a 32 year old man is reported. The patient was unmarried and refused bilateral orchidectomy for its sterile result. He was treated with four courses of methotrexate (MXT) injected in the tunica vaginalis sac. Each course comprised the administration of 50 mg MXT in each tunical sac every 5 days for five consecutive doses followed by 3 weeks rest. No toxicity was encountered. Testicular biopsy 6 months after the start of treatment was negative for malignant cells. A temporary drop of sperm count occurred during treatment. Treatment was performed 6 years ago, and the patient has had no recurrence and is fertile. The treatment was done on an outpatient basis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8490198     DOI: 10.1097/00001813-199304000-00010

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  2 in total

1.  Potential Gonado-Protective Effect of Cichorium endivia and Its Major Phenolic Acids against Methotrexate-Induced Testicular Injury in Mice.

Authors:  Enas E Eltamany; Esraa M Mosalam; Eman T Mehanna; Basma M Awad; Sarah M Mosaad; Maged S Abdel-Kader; Amany K Ibrahim; Jihan M Badr; Marwa S Goda
Journal:  Biomedicines       Date:  2022-08-16

2.  Acute anejaculation, hypogonadism, and fertility preservation in the setting of neurosarcoidosis: case report and literature review.

Authors:  Benjamin Yu; Anne L Darves-Bornoz; Robert E Brannigan; Joshua A Halpern
Journal:  F S Rep       Date:  2020-10-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.